INTRODUCTION Print Section Listen Cancer staging systems have been designed to provide both physicians and patients with a metric for assessing the extent of disease and prognosis. Staging systems provide…
INTRODUCTION Print Section Listen Pancreatic neuroendocrine tumors (PNETs) are tumors that originate from the islet cells of the pancreas and are also often referred to as islet cell tumors. With…
INTRODUCTION Print Section Listen Pancreatic ductal adenocarcinoma (PDA) is the fourth leading cause of cancer-related deaths in the United States and the eighth worldwide. Despite advances in medical therapy, survival…
INTRODUCTION Print Section Listen Palliative care is an approach to care that improves the quality of life of patients and their families facing the problems associated with life-threatening illness, through…
INTRODUCTION Print Section Listen Background The treatment of cancer patients has become complex as a result of the introduction of new therapies and insights into how to use these therapies….
INTRODUCTION Print Section Listen Cancer is fundamentally a genetic disease that develops when alterations in multiple genes result in dysregulation of a select number of cellular pathways and processes. In…
GENERAL CONSIDERATIONS Print Section Listen Gallbladder cancer is an aggressive malignancy with a generally poor prognosis. Described for the first time in two autopsy cases by Stoll and his colleagues…
OVERVIEW Print Section Listen Cholangiocarcinoma is a diverse group of rare but highly fatal malignancies arising from the biliary tract epithelium. According to their anatomical origin in the biliary tract,…
INTRODUCTION Print Section Listen Neuroendocrine tumors (NETs) represent a spectrum of histologies which share the ability to secrete hormonal or vasoactive peptides.1 The most common NETs are carcinoid and pancreatic…
INTRODUCTION Print Section Listen Intrahepatic cholangiocarcinoma (IHCC) is the second most frequent primary malignant tumor of the liver after hepatocellular carcinoma (HCC). IHCCs are considered as primary intrahepatic liver tumors….
